ResearcherUniversity of Tennessee Health Science CenterNo recent work listed

Manjul Rana

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-5371-807X; OpenAlex author ID A5088560955. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-23-0149 ↗
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antit… Co-author DOI 10.1002/mc.23401 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Evan Scott Glazer · 2 shared papers, 2022–2023 · strength 0.34
- Paper Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-23-0149 ↗
- Paper The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus du… DOI 10.1002/mc.23401 ↗
Mehdi Chaib · 1 shared paper, 2022 · strength 0.15
- Paper The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus du… DOI 10.1002/mc.23401 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.